Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Elevated vascular endothelial growth factor level in Coats' disease and possible therapeutic role of bevacizumab.
[coats disease]
To
compare
intraocular
vascular
endothelial
growth
factor
(
VEGF
)
level
in
patients
with
and
without
Coats
'
disease
,
and
to
report
a
case
of
Coats
'
disease
that
responded
to
intravitreal
injection
of
bevacizumab
.
Intraocular
fluid
was
obtained
from
four
eyes
with
Coats
'
disease
(
subretinal
fluid
in
three
eyes
and
aqueous
in
one
eye
)
and
from
five
eyes
with
rhegmatogenous
retinal
detachment
(
subretinal
fluid
in
four
eyes
and
vitreous
in
one
eye
)
.
Intraocular
VEGF
level
was
compared
between
these
two
groups
.
In
one
eye
with
stage
2
B
Coats
'
disease
,
macular
edema
,
visual
acuity
,
and
intraocular
VEGF
level
were
compared
before
and
after
intravitreal
injection
of
bevacizumab
.
Mean
intraocular
VEGF
level
in
eyes
with
Coats
'
disease
was
2
,
394
.
5
pg
/
ml
,
compared
to
15
.
3
pg
/
ml
in
eyes
with
rhegmagenous
retinal
detachment
.
In
the
eye
with
stage
2
B
Coats
'
disease
,
macular
edema
was
reduced
after
bevacizumab
injection
,
and
the
visual
acuity
improved
from
0
.
05
to
0
.
2
.
Intraocular
VEGF
level
decreased
from
1247
pg
/
ml
to
20
.
4
pg
/
ml
1
month
after
the
injection
.
Coats
'
disease
is
associated
with
increased
intraocular
VEGF
level
.
Bevacizumab
may
be
a
valuable
adjunctive
treatment
for
Coats
'
disease
.
Diseases
Validation
Diseases presenting
"growth factor"
symptom
22q11.2 deletion syndrome
achondroplasia
adrenal incidentaloma
aniridia
cadasil
cholangiocarcinoma
coats disease
dedifferentiated liposarcoma
dentin dysplasia
dentinogenesis imperfecta
dystrophic epidermolysis bullosa
esophageal carcinoma
esophageal squamous cell carcinoma
hodgkin lymphoma, classical
holt-oram syndrome
inclusion body myositis
kallmann syndrome
krabbe disease
liposarcoma
lymphangioleiomyomatosis
oculocutaneous albinism
oral submucous fibrosis
pleomorphic liposarcoma
primary effusion lymphoma
primary hyperoxaluria type 1
severe combined immunodeficiency
systemic capillary leak syndrome
von hippel-lindau disease
wolf-hirschhorn syndrome
x-linked adrenoleukodystrophy
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom